SOURCE: CNS Response

CNS Response

June 24, 2011 07:00 ET

CNS Response Announces Filing of Registration Statement and Preliminary Prospectus

ALISO VIEJO, CA--(Marketwire - Jun 24, 2011) - CNS Response, Inc. (OTCBB: CNSO) announced today that it has filed a preliminary prospectus with the securities regulatory authorities in each of the provinces of Canada, other than Quebec, in connection with a best efforts initial public offering of securities in each of the provinces of Canada, other than Quebec, which offering will be conducted simultaneously in the United States pursuant to a registration statement filed with the United States Securities and Exchange Commission.

Paradigm Capital, Inc. and Mackie Research Capital Corporation will act as placement agents in Canada, other than Quebec, and Paradigm Capital U.S. Inc., Noble Financial Capital Markets and Mackie Research USA Inc. will act as placement agents in the United States, in connection with the offering.

A copy of the Canadian preliminary prospectus is available on SEDAR at The Canadian preliminary prospectus is subject to completion or amendment. Copies of the Canadian preliminary prospectus may be obtained from Paradigm Capital, Inc. or Mackie Research Capital Corporation. There will not be any sale or any acceptance of an offer to buy the securities in Canada until a receipt for the final prospectus has been issued by the securities regulatory authorities.

A registration statement relating to these securities has been filed with the United States Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. Copies of the U.S. preliminary prospectus and, when available, the U.S. final prospectus, may be obtained at the United States Securities and Exchange Commission web site at, or from Paradigm Capital, Inc., 95 Wellington Street West, Suite 2101, PO Box 55, Toronto, Ontario, Canada, M5J 2N7.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, and there shall be no sale of these securities in any state, province or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province or jurisdiction.

About CNS Response
CNS Response provides reference data and analytic tools for clinicians and researchers through the Psychiatric EEG Evaluation Registry, or PEER Online™, which serves as a platform for medical professionals to exchange treatment outcome data referenced to objective neurophysiology data from EEG.

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed are forward-looking statements. These forward-looking statements include, without limitation, statements regarding: proposed new products or services; CNS Response's statements concerning litigation or other matters; statements concerning projections, predictions, expectations, estimates or forecasts for CNS Response's business, financial and operating results and future economic performance; statements of management's goals and objectives; trends affecting CNS Response's financial condition, results of operations or future prospects; CNS Response's financing plans or growth strategies; and other similar expressions concerning matters that are not historical facts. Words such as "may," "will," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes" and "estimates," and similar expressions, as well as statements in future tense, identify forward-looking statements. These forward-looking statements involve risks and uncertainties as set forth in CNS Response's filings with the United States Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. You should not put undue reliance on any forward-looking statements. The forward-looking statements in this document speak only as of this date, and CNS Response disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.

Contact Information

  • Investor Relations:
    Marty Tullio
    Managing Partner
    McCloud Communications, LLC
    Email Contact

    Media Relations:
    Joyce Johannson
    Johannson Communications
    612.927.4543 (office)
    612.845.3080 (cell)